The metabolic syndrome revisited: "cardiometabolic risk" emerges as common ground between differing views of the ADA and AHA.
Stern
Naftali
N
Institute of Endocrinology, Metabolism and Hypertension, Tel Aviv-Sourasky Medical Center and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel. stern@tasmc.health.gov.il
Izkhakov
Yelena
Y
D000572:American Heart Association; D002318:Cardiovascular Diseases / Q000209:etiology*; D048909:Diabetes Complications / Q000209:etiology*; D050171:Dyslipidemias / Q000150:complications; D005060:Europe; D006801:Humans; D006943:Hyperglycemia / Q000150:complications; D006973:Hypertension / Q000150:complications; D024821:Metabolic Syndrome / Q000150:complications* / Q000175:diagnosis; D009765:Obesity / Q000150:complications; D017410:Practice Guidelines as Topic; D018570:Risk Assessment; D012307:Risk Factors; D009626:Terminology as Topic; D014481:United States; D014837:Voluntary Health Agencies; D014944:World Health Organization